Recent summary of changes to the LAM
The tables below show a summary of changes to the list of approved medicines (LAM) since it was last published. The LAM is published monthly or more frequently if required.
Additions
Faricimab intraocular injection 6mg/0.05mL, vial |
Phenol injection 5% in Oil 5mL |
Amendments
Ruxolitinib tablet 5mg, 10mg |
Ruxolitinib tablet 15mg, 20mg |
Sotrovimab injection 500mg/8mL |
Casirivimab + imdevimab (Ronapreve®) injection 120 mg/mL + 120 mg/mL |
Remdesivir injection 100mg/20mL |
Baricitinib tablet 2mg, 4mg |
Molnupiravir capsule 200mg |
Nirmatrelvir + ritonavir tablets 150mg + 100mg (Paxlovid®) |
Tocilizumab injection 80mg/4mL, 200mg/10mL, 400mg/20mL |
Etanercept injection 50mg (pre-filled syringe, auto-injector) |
Deletions
Fiasp (insulin aspart – fast acting) injection 100 units/mL, 3mL pen device and 10mL vial |
Hydromorphone modified release (MR) tablets 4mg, 8mg, 16mg, 32mg, 64mg |
Last updated: 5 June 2023